Pharmacogenomics of Cancer

Update: 2009-05-14

Description

Frank McCormick discusses how each protein is a problem in the use of pharmaceutics to combat cancer and suggests that developing a platform that can be used for anything is the process that will alter the future of cancer treatment. (September 16, 2008)

Comments

In Channel

Pharmacogenomics of Cancer

2009-05-1400:02

Hedgehog Signaling and Cancer: New Concepts and Therapeutic Opportunities

2009-05-1400:02

Hodgkin's Disease: A Paradigm for Clinical Research

2009-05-1400:02

Targeted Anticancer Therapies

2009-05-1400:03

Chromosomal Aberrations: Entrees to Core Pathways and Biomarkers in Cancer

2009-05-1400:02

Gynecologic Cancers: Translational Research Opportunities

2009-05-1400:03

Translational Research in Acute Leukemia

2009-05-1400:02

Translational Cancer Research in Urological Malignancies

2009-05-1400:01

Imaging of Immune Cell Trafficking Patterns Refines Development of Cell-Based Therapies

2009-05-1400:02

Assessing Genetic Risk for Cancer: Stanford Clinical Cancer Genetics Program

2009-05-1400:02

Targeted Therapy and Vaccines for Breast Cancer

2009-05-1400:02

The Ethical Conduct of Research

2009-05-1400:02

Breast Cancer Prevention Studies

2009-05-1400:02

Head and Neck Cancer

2009-05-1400:01

Pediatrics Cancer

2009-05-1400:02

Hematopoietic and Leukemic Stem Cells

2009-05-1400:03

Cancer and Regenerative Medicine

2009-05-1400:02

Stem Cell Transplantation and Induction of Tolerance

2009-05-1400:01

Dendritic Cell Therapy

2009-05-1400:02

Oncogenes and Cancer: Oncogene Addition, the Achilles Heal of Cancer

2009-05-1400:02

00:00

1.0x

Pharmacogenomics of Cancer

#box-pro-ellipsis-175885720392096{-webkit-line-clamp:2;}Pharmacogenomics of Cancer

Pharmacogenomics of Cancer

Stanford University

Pharmacogenomics of Cancer